The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse? ; volume:21 ; number:1 ; day:21 ; month:8 ; year:2024 ; pages:1-14 ; date:12.2024
Journal of neuroinflammation ; 21, Heft 1 (21.8.2024), 1-14, 12.2024
- Creator
-
Mazziotti, Valentina
Crescenzo, Francesco
Turano, Ermanna
Guandalini, Maddalena
Bertolazzo, Maddalena
Ziccardi, Stefano
Virla, Federica
Camera, Valentina
Marastoni, Damiano
Tamanti, Agnese
Calabrese, Massimiliano
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12974-024-03193-6
- URN
-
urn:nbn:de:101:1-2411072114060.361123354105
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mazziotti, Valentina
- Crescenzo, Francesco
- Turano, Ermanna
- Guandalini, Maddalena
- Bertolazzo, Maddalena
- Ziccardi, Stefano
- Virla, Federica
- Camera, Valentina
- Marastoni, Damiano
- Tamanti, Agnese
- Calabrese, Massimiliano
- SpringerLink (Online service)
Other Objects (12)
Cognitive progression independent of relapse activity in different multiple sclerosis phenotypes
Seasonal variation in multiple sclerosis relapse
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression
Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis
Correction to: Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression
Acute esophageal necrosis: possible association with terlipressin
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis
Real-world evidence of ocrelizumab-treated relapsing multiple sclerosis cohort shows changes in progression independent of relapse activity mirroring phase 3 trials
Tumor necrosis factor mediates USE1-independent FAT10ylation under inflammatory conditions
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis
Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients
Time independent factors that predict relapse in adults with acute myeloid leukemia
Cognitive progression independent of relapse activity in different multiple sclerosis phenotypes
Seasonal variation in multiple sclerosis relapse
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression
Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis
Correction to: Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression
Acute esophageal necrosis: possible association with terlipressin
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis
Real-world evidence of ocrelizumab-treated relapsing multiple sclerosis cohort shows changes in progression independent of relapse activity mirroring phase 3 trials
Tumor necrosis factor mediates USE1-independent FAT10ylation under inflammatory conditions
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis
Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients
Time independent factors that predict relapse in adults with acute myeloid leukemia
Cognitive progression independent of relapse activity in different multiple sclerosis phenotypes
Seasonal variation in multiple sclerosis relapse
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression
Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis
Correction to: Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression
Acute esophageal necrosis: possible association with terlipressin
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis
Real-world evidence of ocrelizumab-treated relapsing multiple sclerosis cohort shows changes in progression independent of relapse activity mirroring phase 3 trials
Tumor necrosis factor mediates USE1-independent FAT10ylation under inflammatory conditions
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis
Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients